{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:40:12Z","timestamp":1788374412390,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.05.029","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T23:23:03Z","timestamp":1590621783000},"page":"4679-4686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6\u20137\u00a0years old in the Solomon Islands, 2016"],"prefix":"10.1016","volume":"38","author":[{"given":"Lucy","family":"Breakwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenniffer","family":"Anga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ropiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gwyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9535-6277","authenticated-orcid":false,"given":"Kathleen","family":"Wannemuehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Woodring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divinal","family":"Ogaoga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania A.","family":"Tohme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.05.029_b0005","doi-asserted-by":"crossref","unstructured":"Lok, A.S., B.J. McMahon, and Practice Guidelines Committee American Association for the Study of Liver Diseases, Chronic hepatitis B. Hepatology, 2001. 34(6): p. 1225-41.","DOI":"10.1053\/jhep.2001.29401"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.029_b0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2020.05.029_b0015","unstructured":"World Health Organization, Hepatitis B vaccines: WHO position paper - July 2017. Weekly Epidemiological Record, 2017. 92: p. 369-392."},{"key":"10.1016\/j.vaccine.2020.05.029_b0020","unstructured":"World Health Organization, Hepatitis B control through vaccination: setting the target. 2015; Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/249167\/WPR_RC066_Res1_2015_en.pdf;jsessionid=D32B657D3E45834C3DF52824CBA3DC9D?sequence=1."},{"key":"10.1016\/j.vaccine.2020.05.029_b0025","unstructured":"World Health Organization, Regional action plan for viral hepatitis in the Western Pacific 2016-2020. 2016; Available from: http:\/\/iris.wpro.who.int\/handle\/10665.1\/13141."},{"key":"10.1016\/j.vaccine.2020.05.029_b0030","unstructured":"World Health Organization, Global health sector strategy on viral hepatitis 2016-2021: towards ending viral hepatitis 2016; Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/246177\/1\/WHO-HIV-2016.06-eng.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2020.05.029_b0035","unstructured":"World Health Organization, Guidelines for certification of achievement of hepatitis B control goal in the Western Pacific Region 2007; Available from: http:\/\/www.wpro.who.int\/immunization\/documents\/HepBControlCertifGuidelines\/en\/."},{"key":"10.1016\/j.vaccine.2020.05.029_b0040","unstructured":"World Health Organization, Elimination of measles and acceleration of rubella control. 2012; Available from: http:\/\/www.wpro.who.int\/about\/regional_committee\/63\/resolutions\/WPR_RC63_R5_Measles_elimination_03Oct.pdf."},{"key":"10.1016\/j.vaccine.2020.05.029_b0045","unstructured":"World Health Organization, Regional strategy and plan of action for measles and rubella elimination in the Western Pacific. 2018; Available from: https:\/\/iris.wpro.who.int\/bitstream\/handle\/10665.1\/14227\/9789290618515-eng.pdf."},{"key":"10.1016\/j.vaccine.2020.05.029_b0050","unstructured":"World Health Organization, Measles vaccines: WHO position paper - April 2017. Weekly Epidemiological Record, 2017. 92(17): p. 205-228."},{"key":"10.1016\/j.vaccine.2020.05.029_b0055","unstructured":"World Health Organization, Rubella vaccines: WHO position paper. Weekly Epidemiological Record, 2011. 86(29): p. 301-316."},{"key":"10.1016\/j.vaccine.2020.05.029_b0060","unstructured":"World Health Organization, Protecting all against tetanus: guide to sustaining maternal and neonatal tetanus elimination (MNTE) and broadening tetanus protection for all populations. 2019; Available from: https:\/\/www.who.int\/immunization\/diseases\/tetanus\/Protecting_All_Against_Tetanus_final_draftV4_23Jan_web.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2020.05.029_b0065","unstructured":"World Health Organization, Tetanus vaccines: WHO position paper - February 2017. World Health Organization Weekly Epidemiological Record, 2017. 92(6): p. 53-76"},{"key":"10.1016\/j.vaccine.2020.05.029_b0070","unstructured":"World Health Organization, Diphtheria vaccine: WHO position paper \u2013 August 2017. Weekly Epidemiological Record, 2017. 92(31): p. 417-436."},{"key":"10.1016\/j.vaccine.2020.05.029_b0075","unstructured":"Solomon Islands National Statistics Office, Demographic and health survey 2006-2007. 2009."},{"key":"10.1016\/j.vaccine.2020.05.029_b0080","unstructured":"Solomon Islands National Statistics Office, Report on 2009 population and housing census: basic tables and census description. 2011."},{"key":"10.1016\/j.vaccine.2020.05.029_b0085","unstructured":"United Nations Population Division, World population prospects. [Accessed March 21, 2019]; Available from: https:\/\/population.un.org\/wpp\/DataQuery\/."},{"key":"10.1016\/j.vaccine.2020.05.029_b0090","unstructured":"UNICEF, Maternal and newborn health coverage dataset. 2019 [Accessed: 04\/27\/2020]; Available from: https:\/\/data.unicef.org\/resources\/dataset\/delivery-care\/."},{"key":"10.1016\/j.vaccine.2020.05.029_b0095","unstructured":"World Health Organization, EPI country profile: Solomon Islands, 2014. 2014; Available from: http:\/\/www.wpro.who.int\/immunization\/documents\/epi_country_poster_2014_sol.pdf."},{"key":"10.1016\/j.vaccine.2020.05.029_b0100","unstructured":"World Health Organization, WHO and UNICEF estimates time series for Solomon Islands (SLB). [Accessed: 27\/04\/2020]; Available from: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/estimates?c=SLB"},{"key":"10.1016\/j.vaccine.2020.05.029_b0105","unstructured":"World Health Organization, Maternal and neonatal tetanus (MNT) elimination: progress towards global MNT elimination.; Available from: https:\/\/www.who.int\/immunization\/diseases\/MNTE_initiative\/en\/index4.html."},{"key":"10.1016\/j.vaccine.2020.05.029_b0110","unstructured":"World Health Organization, Western Pacific regional plan for hepatitis B control through immunization. 2007; Available from: http:\/\/www.wpro.who.int\/immunization\/documents\/docs\/POA_HepB.pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2020.05.029_b0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4269\/ajtmh.1999.61.85","article-title":"Markedly high seroprevalence of hepatitis B virus infection in comparison to hepatitis C virus and human T lymphotropic virus type-1 infections in selected Solomon Islands populations","volume":"61","author":"Furusyo","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.vaccine.2020.05.029_b0120","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/jcm.30.11.2874-2880.1992","article-title":"Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays","volume":"30","author":"Hummel","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.05.029_b0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4269\/ajtmh.19-0365","article-title":"Integrated cross-sectional multiplex serosurveillance of IgG antibody responses to parasitic diseases and vaccines in coastal Kenya","volume":"102","author":"Njenga","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.029_b0130","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1128\/JCM.02572-15","article-title":"Evaluation of multiplex-based antibody testing for use in large-scale surveillance for yaws: a comparative study","volume":"54","author":"Cooley","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.029_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004699","article-title":"Integration of multiplex bead assays for parasitic diseases into a national, population-based serosurvey of women 15\u201339 years of age in Cambodia","volume":"10","author":"Priest","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2020.05.029_b0140","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/CVI.05207-11","article-title":"Evaluation of the Bio-Rad BioPlex measles, mumps, rubella, and varicella-zoster virus IgG multiplex bead immunoassay","volume":"18","author":"Binnicker","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.05.029_b0145","first-page":"872","article-title":"Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for quantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b","volume":"9","author":"Pickering","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2020.05.029_b0150","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/CVI.00052-16","article-title":"Tetanus immunity among women aged 15 to 39 Years in Cambodia: a national population-based serosurvey, 2012","volume":"23","author":"Scobie","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.029_b0155","first-page":"1022","article-title":"Relevance and criticality in an external quality assessment for the determination of diphtheria antitoxin","volume":"2","author":"von Hunolstein","year":"2014","journal-title":"J Immunol Clin Res"},{"issue":"6","key":"10.1016\/j.vaccine.2020.05.029_b0160","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4269\/ajtmh.16-0665","article-title":"Multiplex serologic assessment of schistosomiasis in western Kenya: antibody responses in preschool aged children as a measure of reduced transmission","volume":"96","author":"Won","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.vaccine.2020.05.029_b0165","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1699-0463.1997.tb05093.x","article-title":"Improved ELISA for determination of anti-diphtheria and\/or anti-tetanus antitoxin antibodies in sera","volume":"105","author":"Kristiansen","year":"1997","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2020.05.029_b0170","unstructured":"Borrow, R., P. Balmer, and M.H. Roper, The immunological basis for immunization series Module 3:Tetanus update 2006. 2007; Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/43687\/1\/9789241595551_eng.pdf."},{"key":"10.1016\/j.vaccine.2020.05.029_b0175","unstructured":"Scheifele, D.W. and J.J. Ochnio, The immunological basis for immunization series module 2: Diphtheria update 2009. 2009; Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/44094\/1\/9789241597869_eng.pdf."},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.029_b0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity. Defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2020.05.029_b0185","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3389\/fimmu.2018.01402","article-title":"Impact of mothers' schistosomiasis status during gestation on children's IgG antibody responses to routine vaccines 2 years later and anti-schistosome and anti-malarial responses by neonates in western Kenya","volume":"9","author":"Ondigo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.05.029_b0190","unstructured":"Bentley, M., P. Christian, B.J. Cohen, and A. Heath, Report of a collaborative study to assess the suitability of a replacement for the 2nd international standard for anti-measles serum. 2006; Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/70612\/1\/WHO_BS_06.2031_eng.pdf."},{"key":"10.1016\/j.vaccine.2020.05.029_b0195","unstructured":"World Health Organization, Measles elimination, hepatitis B control and poliomyelitis eradication. 2005 WPR\/RC56.R8; Available from: http:\/\/www2.wpro.who.int\/rcm\/en\/archives\/rc56\/rc_resolutions\/wpr_rc56_r08.htm."},{"key":"10.1016\/j.vaccine.2020.05.029_b0200","unstructured":"World Health Organization, Temperature sensitivity of vaccines. 2006; Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/69387\/1\/WHO_IVB_06.10_eng.pdf."},{"issue":"46","key":"10.1016\/j.vaccine.2020.05.029_b0205","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1016\/j.vaccine.2014.08.078","article-title":"Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine","volume":"32","author":"Zhang","year":"2014","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2020.05.029_b0210","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.vaccine.2017.04.011","article-title":"Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: identifying opportunities and barriers to implementation","volume":"35","author":"Breakwell","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.029_b0215","unstructured":"World Health Organization, Preventing perinatal hepatitis B virus transmission: a guide for introducing and strengthening hepatitis B birth dose vaccination. 2015; Available from:https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/208278\/9789241509831_eng.pdf;sequence=1 ."},{"key":"10.1016\/j.vaccine.2020.05.029_b0220","unstructured":"World Health Organization, Consultation on improving and monitoring hepatitis B birth dose vaccination. 2012; Available from: http:\/\/www.wpro.who.int\/hepatitis\/consultation_hepb_birthdose_june2012_mtgrpt.pdf."},{"key":"10.1016\/j.vaccine.2020.05.029_b0225","unstructured":"World Health Organization, Measles outbreak, Solomon Islands. Health Situation Report 2014; Available from: http:\/\/reliefweb.int\/report\/solomon-islands\/measles-outbreak-solomon-islands-healthsituation-report-no-7."},{"key":"10.1016\/j.vaccine.2020.05.029_b0230","unstructured":"World Health Organization, Solomon Islands country profile - measles elimination. 2014; Available from: http:\/\/www.wpro.who.int\/immunization\/documents\/measles_country_profile_nov2014_sol.pdf."},{"key":"10.1016\/j.vaccine.2020.05.029_b0235","unstructured":"World Health Organization, Replacement of TT with Td vaccine for dual protection. 2018; Available from: https:\/\/www.who.int\/immunization\/diseases\/tetanus\/WHO_UNICEF_Joint_communique_on_TT_to_Td_Replacement_Final28June2018.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2020.05.029_b0240","unstructured":"World Health Organization, Hepatitis B surface antigen assays: operational characteristics (phase 1). 2001; Available from: http:\/\/www.who.int\/diagnostics_laboratory\/evaluations\/en\/hep_B_rep1.pdf."},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.029_b0245","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jhep.2012.11.016","article-title":"Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort","volume":"58","author":"Bottero","year":"2013","journal-title":"France. J Hepatol"},{"issue":"10","key":"10.1016\/j.vaccine.2020.05.029_b0250","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/JCM.00498-08","article-title":"Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity","volume":"46","author":"Lin","year":"2008","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20306484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20306484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:40:29Z","timestamp":1762278029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20306484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":50,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20306484"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6\u20137\u00a0years old in the Solomon Islands, 2016","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}